Notice of NIBIB's Participation in PA-14-308 "Platform Delivery Technologies for Nucleic Acid Therapeutics (R41/R42)"

Notice Number: NOT-EB-14-005

Key Dates
Release Date:   August 21, 2014

Related Announcements
PA-14-308

Issued by
National Institute of Biomedical Imaging and Bioengineering (NIBIB)

Purpose

The purpose of this Notice is to inform potential applicants of the National Institute of Biomedical Imaging and Bioengineering (NIBIB)'s participation, effective immediately, in PA-14-308 "Platform Delivery Technologies for Nucleic Acid Therapeutics (R41/R42)."

The following sections of PA-14-308 have been updated to reflect the participation of NIBIB in this FOA:

Part 1. Overview Information

Components of Participating Organizations:
National Center for Advancing Translational Sciences (NCATS)
National Institute on Drug Abuse (NIDA)
National Institute of Biomedical Imaging and Bioengineering (NIBIB)

Catalog of Federal Domestic Assistance (CFDA) Number(s)
93.350, 93.279, 93.286  

Part 2. Section VII. Agency Contacts

Scientific/Research Contact(s)
Jessica Tucker, Ph.D. 
National Institute of Biomedical Imaging and Bioengineering (NIBIB) 
Telephone: 301-451-4778
Email: tuckerjm@mail.nih.gov

Financial/Grants Management Contact(s)
James Huff
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
Telephone: 301-451-4786
Email: huffj@mail.nih.gov

All other aspects of this FOA remain the same.

Inquiries

Please direct all inquiries to:

Jessica Tucker, Ph.D.
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
Telephone: 301-451-4778
Email: tuckerjm@mail.nih.gov

 

NIH Office of Extramural Research Logo
Department of Health and Human Services (HHS) - Home Page
Department of Health
and Human Services (HHS)
USA.gov - Government Made Easy
NIH... Turning Discovery Into Health®


Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files.